Search results
Das Paul-Ehrlich-Institut ist ein Bundesinstitut im Geschäftsbereich des Bundesministeriums für Gesundheit. Es fördert durch Forschung und Prüfung die Qualität, Wirksamkeit und Sicherheit biomedizinischer Arzneimittel.
He was the founder and first director of what is now known as the Paul Ehrlich Institute, a German research institution and medical regulatory body that is the nation's federal institute for vaccines and biomedicines.
Since 1 October 2022, no new participants can register for the SafeVac 2.0 study. The tracking of the persons registered up to that point remains unchanged. After completion of the data collection at the end of 2023, the Paul-Ehrlich-Institut will evaluate the study and publish the results.
Jan 14, 2016 · The internationally recognised research conducted by the Paul-Ehrlich-Institut in the fields of virology, immunology, allerology, haematology, cell and genetic therapy improves the quality, safety and effectiveness of biomedicines.
Germany paused vaccinations on Monday on the recommendation of the Paul Ehrlich Institute (PEI), the country's agency in charge of vaccine safety. PEI head Klaus Cichutek says all seven cases of CVT had occurred between 4 and 16 days after vaccination, and that an analysis suggested only a single case would normally be expected among the 1.6 ...
Aug 3, 2022 · The figures come from the country’s Paul-Ehrlich-Institut, which is the Federal Institute for Vaccines and Biomedicines and is responsible for overseeing the safety of medicines, much like the FDA.
Feb 5, 2016 · As Director of the Georg-Speyer-Haus, Paul Ehrlich greatly intensified the production and testing of various chemical compounds; by doing so, he established the principles of chemotherapy, and finally he developed Salvarsan® in his institute. In 1908, Paul Ehrlich received the Nobel Prize in Physiology or Medicine together with Elie ...
